A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
- Registry updated
- 2023-09-13
- Study type / phase
- interventional · phase2
- Enrollment
- 338 (actual)
- Interventions
- LY3437943; Placebo
- Registry results
- Posted 2023-09-13 · Read the results tables
Listed study locations (28)
Locations remain in completed records. A listed site is not necessarily recruiting. The trial team determines eligibility and availability.
- Perseverance Research Center, Scottsdale, Arizona, United States — site status not supplied
- Anaheim Clinical Trials, LLC, Anaheim, California, United States — site status not supplied
- Valley Research, Fresno, California, United States — site status not supplied
- Velocity Clinical Research, Huntington Park, Huntington Park, California, United States — site status not supplied
- Velocity Clinical Research, Huntington Park, Los Angeles, California, United States — site status not supplied
- Southern California Dermatology, Inc., Santa Ana, California, United States — site status not supplied
- Coastal Metabolic Research Centre, Ventura, California, United States — site status not supplied
- Diablo Clinical Research, Inc., Walnut Creek, California, United States — site status not supplied
- East Coast Institute for Research, LLC, Jacksonville, Florida, United States — site status not supplied
- Suncoast Clinical Research, Inc., New Port Richey, Florida, United States — site status not supplied
- Encore Medical Research - Weston, Weston, Florida, United States — site status not supplied
- Springfield Diabetes & Endocrine Center, Springfield, Illinois, United States — site status not supplied
- Cotton O'Neil Diabetes and Endocrinology Center, Topeka, Kansas, United States — site status not supplied
- Tandem Clinical Research,LLC, Marrero, Louisiana, United States — site status not supplied
- StudyMetrix Research, City of Saint Peters, Missouri, United States — site status not supplied
- Amici Clinical Research LLC, Raritan, New Jersey, United States — site status not supplied
- Intend Research, LLC, Norman, Oklahoma, United States — site status not supplied
- Allegheny Endocrinology Associates, Pittsburgh, Pennsylvania, United States — site status not supplied
- New Phase Research and Development, Knoxville, Tennessee, United States — site status not supplied
- Texas Diabetes & Endocrinology, P.A., Austin, Texas, United States — site status not supplied
- Dallas Diabetes Research Center, Dallas, Texas, United States — site status not supplied
- Juno Research, Houston, Texas, United States — site status not supplied
- Endocrine Ips, Pllc, Houston, Texas, United States — site status not supplied
- Southern Endocrinology Associates, Mesquite, Texas, United States — site status not supplied
- Rainier Clinical Research Center, Renton, Washington, United States — site status not supplied
- Private Practice - Dr. Paola Mansilla-Letelier, Guaynabo, Puerto Rico — site status not supplied
- GCM Medical Group, PSC - Hato Rey Site, San Juan, Puerto Rico — site status not supplied
- San Juan City Hospital, San Juan, Puerto Rico — site status not supplied
Publications linked by the registry (4)
These are registry references, including background references. Their presence does not establish that they report this trial's results or have been reviewed by Monday.
- PubMed 42608321 · derived
- PubMed 41201783 · derived
- PubMed 38858523 · derived
- PubMed 37366315 · derived
